FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

MD Mayes

Research Profile

Disorders

Concepts & Ideas

Procedures

Activities & Behaviors

Questionnaires

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Living Beings

European Continental Ancestry Group

Geographic Areas

Co-author Network

Publications

TOP 3
Emily W Hung; Lynette Keyes-Elstein; Dinesh Khanna; Sharon Leclercq; Victor I Machicao; MD Mayes; Peter McSweeney; Shin Mineishi; Richard A Nash; Kristine Phillips; James R Seibold; Roozbeh Sharif; Robert W Simms; E William St Clair; Jan Storek; Shervin Assassi; Karen Ballen; Christopher N Bredeson; Sharon Castina; Leslie J Crofford; Mary Ellen Csuka; Stephen Forman; Daniel E Furst; Ellen Goldmuntz; Chitra Hosing; Beverly Welch; Mark H Wener; Keith M Sullivan
Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.
Erin L Merz; Deepthi K Nair; Scott C Roesch; Roozbeh Sharif; Shervin Assassi; Hilda T Draeger; Emilio B Gonzalez; Brock E Harper; Vanessa L Malcarne; Terry A McNearney; MD Mayes
Measuring illness behavior in patients with systemic sclerosis.
Xiaochun Liu; MD Mayes; John D Reveille; Filemon K Tan; Minghua Wu; Hilda T Draeger; Emilio B Gonzalez; Brock E Harper; Shervin Assassi
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of MD Mayes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emily W Hung; Lynette Keyes-Elstein; Dinesh Khanna; Sharon Leclercq; Victor I Machicao; MD Mayes; Peter McSweeney; Shin Mineishi; Richard A Nash; Kristine Phillips; James R Seibold; Roozbeh Sharif; Robert W Simms; E William St Clair; Jan Storek; Shervin Assassi; Karen Ballen; Christopher N Bredeson; Sharon Castina; Leslie J Crofford; Mary Ellen Csuka; Stephen Forman; Daniel E Furst; Ellen Goldmuntz; Chitra Hosing; Beverly Welch; Mark H Wener; Keith M Sullivan
Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.
The Journal of rheumatology 2013;40(4):455-60.
2013: Erin L Merz; Deepthi K Nair; Scott C Roesch; Roozbeh Sharif; Shervin Assassi; Hilda T Draeger; Emilio B Gonzalez; Brock E Harper; Vanessa L Malcarne; Terry A McNearney; MD Mayes
Measuring illness behavior in patients with systemic sclerosis.
Arthritis care & research 2013;65(4):585-93.
2013: Xiaochun Liu; MD Mayes; John D Reveille; Filemon K Tan; Minghua Wu; Hilda T Draeger; Emilio B Gonzalez; Brock E Harper; Shervin Assassi
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis.
Arthritis and rheumatism 2013;65(1):226-35.
2012: Peter A Merkel; R P Polisson; J E Pope; James R Seibold; N P Silliman; James B Streisand; Philip J Clements; Christopher P Denton; Daniel E Furst; MD Mayes
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis.
Arthritis and rheumatism 2012;64(10):3420-9.
2012: Sangmee Bae; Marcy B Bolster; Lorinda Chung; Mary Ellen Csuka; Chris Derk; Robyn Domsic; Aryeh Fischer; Tracy Frech; Daniel E Furst; Avram Goldberg; Monique Hinchcliff; Vivien Hsu; Laura K Hummers; Paul Maranian; MD Mayes; Vallerie V McLaughlin; Jerry Molitor; Nausheen Naz; Rajeev Saggar; Elena Schiopu; Virginia Steen; Dinesh Khanna
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.
Annals of the rheumatic diseases 2012;71(8):1335-42.
2012: Roozbeh Sharif; Filemon K Tan; Fredrick M Wigley; Jun Ying; Sandeep K Agarwal; Frank C Arnett; Lara Bossini-Castillo; Hilda T Draeger; Daniel E Furst; Emilio B Gonzalez; Olga Y Gorlova; Laura K Hummers; Dinesh Khanna; Javier Martin; MD Mayes; John D Reveille; Ami Shah; Shervin Assassi
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.
Annals of the rheumatic diseases 2012;71(7):1197-202.
2012: Baptiste Coustet; Jean-Luc CRACOWSKI; Philippe Dieudé; Elisabeth Diot; Muriel Elhai; Camille Frances; pravitt gourh; Mickael Guedj; Eric Hachulla; André Kahan; Eugénie Koumakis; Javier Martin; MD Mayes; Olivier Meyer; Luc Mouthon; Timothy Radstake; Barbara Ruiz; Jean Sibilia; Kiet Phong TIEV; Zahir Amoura; Frank Arnett; Jérome Avouac; catherine boileau; Lara Bossini-Castillo; Matthieu Bouaziz; Patrick Carpentier; Gilles Chiocchia; Anne Cosnes; Sandeep Agarwal; Yannick Allanore
Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis.
The Journal of rheumatology 2012;39(5):997-1003.
2012: F David Carmona; Patricia Carreira; María Victoria Egurbide; Mónica Fernández-Castro; Paloma García de la Peña; Francisco J García-Hernández; pravitt gourh; Ramana Gutala; Javier Martín; Lina Martínez-Estupiñán; MD Mayes; Norberto Ortego Centeno; Carmen P Simeón; Filemon K Tan; Betty P Tsao; Esther Vicente-Rabaneda; Sandeep K Agarwal; Frank C Arnett; Shervin Assassi
Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.
Annals of the rheumatic diseases 2012;71(1):114-9.
2011: Dinesh Khanna; Paul Maranian; MD Mayes; Rajan Saggar; Rajeev Saggar; Ram R Singh; Fereidoun Abtin; Shervin Assassi; Philip J Clements; Daniel E Furst
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease.
Arthritis and rheumatism 2011;63(11):3540-6.
2011: Prateek Chaudhary; Xing Chen; Hilda T Draeger; Emilio Gonzalez; Olga Gorlova; Brock E Harper; Frank C Arnett; Shervin Assassi; Terry A McNearney; Marilyn Perry; MD Mayes
Cigarette smoking is not a risk factor for systemic sclerosis.
Arthritis and rheumatism 2011;63(10):3098-102.
2011: Dinesh Khanna; Paul Maranian; MD Mayes; James R Seibold; Philip J Clements; Daniel E Furst; Terri Getzug; ann impens; Ron D Hays
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
The Journal of rheumatology 2011;38(9):1920-4.
2011: Roozbeh Sharif; Richard M Silver; Robert W Simms; Xiaodong Zhou; Sandeep K Agarwal; Shervin Assassi; Murray Baron; Julio Charles; Deborah J Del Junco; Hilda T Draeger; Marvin J Fritzler; Daniel E Furst; Emilio B Gonzalez; Dinesh K Khanna; MD Mayes; Terry A McNearney; Jerry A Molitor; Marilyn Perry; Kristine Phillips; John D Reveille; Carlos Rojo; Elena Schiopu; James R Seibold; Frank C Arnett
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
The Journal of rheumatology 2011;38(8):1622-30.
2011: Roozbeh Sharif; Frank C Arnett; Shervin Assassi; Hilda T Draeger; Rosa M Estrada-Y-Martin; Emilio B Gonzalez; MD Mayes; Terry A McNearney; Deepthi K Nair; Perry M Nicassio; John D Reveille
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.
Seminars in arthritis and rheumatism 2011;41(1):38-47.
2011: Baptiste Coustet; Sandeep K Agarwal; pravitt gourh; Mickael Guedj; MD Mayes; Philippe Dieude; Julien Wipff; Jérome Avouac; Eric Hachulla; Elisabeth Diot; Jean-Luc CRACOWSKI; Kiet Phong TIEV; Jean Sibilia; Luc Mouthon; Camille Frances; Zahir Amoura; Patrick Carpentier; Olivier Meyer; Andre Kahan; catherine boileau; Frank C Arnett; Yannick Allanore
Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts.
The Journal of rheumatology 2011;38(6):1033-8.
2011: Chitra Hosing; Richard Nash; Peter McSweeney; Shin Mineishi; James Seibold; Linda M Griffith; Howard Shulman; Ellen Goldmuntz; MD Mayes; chirag parikh; Leslie Crofford; Lynette Keyes-Elstein; Daniel Furst; Virginia Steen; Keith M Sullivan
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(5):674-81.
2011: Binh Nguyen; MD Mayes; Frank C Arnett; Deborah del Junco; John D Reveille; Emilio B Gonzalez; Hilda T Draeger; Marilyn Perry; Amir Hendiani; Kiran K Anand; Shervin Assassi
HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.
Arthritis and rheumatism 2011;63(2):530-4.
2011: Mahsa Nashid; Puja P Khanna; Daniel E Furst; Philip J Clements; Paul Maranian; James R Seibold; Arnold E Postlethwaite; James S Louie; MD Mayes; Harsh Agrawal; Dinesh Khanna
Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials.
Rheumatology (Oxford, England) 2011;50(2):335-42.
2011: Vijay Bodukam; Ron D Hays; Paul Maranian; Daniel E Furst; James R Seibold; ann impens; MD Mayes; Philip J Clements; Dinesh Khanna
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.
Rheumatology (Oxford, England) 2011;50(2):330-4.
2011: Shervin Assassi; Michael Fischbach; Emilio B Gonzalez; Astrud L Leyva; MD Mayes; Terry A McNearney; Deepthi K Nair; Ngan Nguyen; John D Reveille; Roozbeh Sharif
Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.
PloS one 2011;6(10):e26061.
2011: Sandeep K Agarwal; Frank C Arnett; Christopher K Livingston; MD Mayes; Donald H Parks; Minghua Wu; Filemon K Tan
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.
Arthritis research & therapy 2011;13(1):R3.
2011: Shervin Assassi; John D Reveille; Frank C Arnett; Michael H Weisman; Michael M Ward; Sandeep K Agarwal; pravitt gourh; Jiten Bhula; Roozbeh Sharif; Keeran Sampat; MD Mayes; Filemon K Tan
Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5.
The Journal of rheumatology 2011;38(1):87-98.
2010: Karen Au; MD Mayes; Paul Maranian; Philip J Clements; Dinesh Khanna; Virginia D Steen; Donald Tashkin; Michael D Roth; Robert Elashoff; Daniel E Furst
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study.
Arthritis care & research 2010;62(12):1772-8.
2010: Michael A Kallen; MD Mayes; Yana L Kriseman; Sofia B de Achaval; Vanessa L Cox; Maria E Suarez-Almazor
The symptom burden index: development and initial findings from use with patients with systemic sclerosis.
The Journal of rheumatology 2010;37(8):1692-8.
2010: Rajpreet K Arora-Singh; Shervin Assassi; Deborah J Del Junco; Frank C Arnett; Marilyn Perry; Uzma Irfan; Roozbeh Sharif; Tony Mattar; MD Mayes
Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.
Journal of autoimmunity 2010;35(1):52-7.
2010: Binh Nguyen; Shervin Assassi; Frank C Arnett; MD Mayes
Association of RNA polymerase III antibodies with scleroderma renal crisis.
The Journal of rheumatology 2010;37(5):1068; author reply 1069.
2010: Tonya Cockrill; Deborah J Del Junco; Frank C Arnett; Shervin Assassi; Filemon K Tan; Terry A McNearney; Michael Fischbach; Marilyn Perry; MD Mayes
Separate influences of birth order and gravidity/parity on the development of systemic sclerosis.
Arthritis care & research 2010;62(3):418-24.
2010: pravitt gourh; Sandeep K Agarwal; Ezequiel Martin; Dipal Divecha; Blanca Rueda; Haley Bunting; Shervin Assassi; Gene Paz; Sanjay Shete; Terry McNearney; Hilda T Draeger; John D Reveille; T R D J Radstake; Carmen P Simeon; Luis Rodriguez; Esther Vicente; Miguel A Gonzalez-Gay; MD Mayes; Filemon K Tan; Javier Martin; Frank C Arnett
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.
Journal of autoimmunity 2010;34(2):155-62.
2010: pravitt gourh; Frank C Arnett; Filemon K Tan; Shervin Assassi; Dipal Divecha; Gene Paz; Terry McNearney; Hilda T Draeger; John D Reveille; MD Mayes; Sandeep K Agarwal
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.
Annals of the rheumatic diseases 2010;69(3):550-5.
2010: Shervin Assassi; MD Mayes; Frank C Arnett; pravitt gourh; Sandeep K Agarwal; Terry A McNearney; Damien Chaussabel; Nancy Oommen; Michael Fischbach; Kairav R Shah; Julio Charles; Virginia Pascual; John D Reveille; Filemon K Tan
Systemic sclerosis and lupus: points in an interferon-mediated continuum.
Arthritis and rheumatism 2010;62(2):589-98.
2010: Shervin Assassi; Roozbeh Sharif; Robert E Lasky; Terry A McNearney; Rosa M Estrada-Y-Martin; Hilda T Draeger; Deepthi K Nair; Marvin J Fritzler; John D Reveille; Frank C Arnett; MD Mayes
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.
Arthritis research & therapy 2010;12(5):R166.
2009: Xiaodong Zhou; Jong Eun Lee; Frank C Arnett; Momiao Xiong; Min Young Park; Yeon-Kyeong Yoo; Eun Soon Shin; John D Reveille; MD Mayes; Jin Hyun Kim; Ran Song; Ji Yong Choi; Ji Ah Park; Yun Jong Lee; Eun Young Lee; Yeong Wook Song; Eun Bong Lee
HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.
Arthritis and rheumatism 2009;60(12):3807-14.
2009: pravitt gourh; Sandeep K Agarwal; Dipal Divecha; Shervin Assassi; Gene Paz; Rajpreet K Arora-Singh; John D Reveille; Sanjay Shete; MD Mayes; Frank C Arnett; Filemon K Tan
Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.
Arthritis and rheumatism 2009;60(12):3794-806.
2009: Terry A McNearney; Sonya E Hunnicutt; Michael Fischbach; Alan W Friedman; Martha Aguilar; Chul Ahn; John D Reveille; Jeffrey Lisse; Bruce Baethge; Niti Goel; MD Mayes
Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine.
The Journal of rheumatology 2009;36(12):2724-32.
2009: Sandeep K Agarwal; pravitt gourh; Sanjay Shete; Gene Paz; Dipal Divecha; John D Reveille; Shervin Assassi; Filemon K Tan; MD Mayes; Frank C Arnett
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis.
The Journal of rheumatology 2009;36(12):2715-23.
2009: Shervin Assassi; Deborah Del Junco; Kari Sutter; Terry A McNearney; John D Reveille; Andrew Karnavas; pravitt gourh; Rosa M Estrada-Y-Martin; Michael Fischbach; Frank C Arnett; MD Mayes
Clinical and genetic factors predictive of mortality in early systemic sclerosis.
Arthritis and rheumatism 2009;61(10):1403-11.
2009: Dinesh Khanna; Oliver Distler; Jerome Avouac; Frank Behrens; Philip J Clements; Christopher Denton; Ivan Foeldvari; Edward Giannini; Doerte Huscher; Otylia Kowal-Bielecka; Daniel Lovell; Marco Matucci-Cerinic; MD Mayes; Peter A Merkel; Peter Nash; Christian F Opitz; David Pittrow; Lewis Rubin; James R Seibold; Virginia D Steen; C Vibeke Strand; Peter S Tugwell; John Varga; Angela Zink; Daniel E Furst
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
The Journal of rheumatology 2009;36(10):2356-61.
2009: Shervin Assassi; Marvin J Fritzler; Frank C Arnett; Gary L Norman; Kairav R Shah; pravitt gourh; Neil Manek; Marilyn Perry; Devi Ganesh; Mohammad H Rahbar; MD Mayes
Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.
The Journal of rheumatology 2009;36(10):2250-6.
2009: Dinesh Khanna; Ron D Hays; Paul Maranian; James R Seibold; ann impens; MD Mayes; Philip J Clements; Terri Getzug; Nihal Fathi; Amber Bechtel; Daniel E Furst
Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Arthritis and rheumatism 2009;61(9):1257-63.
2009: Dinesh Khanna; Philip J Clements; Daniel E Furst; Joseph H Korn; Michael H Ellman; Naomi F Rothfield; Fredrick M Wigley; Larry W Moreland; Richard M Silver; Youn H Kim; Virginia D Steen; Gary S Firestein; Arthur F Kavanaugh; Michael Weisman; MD Mayes; David Collier; Mary E Csuka; Robert W Simms; Peter A Merkel; Thomas A Medsger; Martin E Sanders; Paul Maranian; James R Seibold
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2009;60(4):1102-11.
2009: pravitt gourh; Frank C Arnett; Shervin Assassi; Filemon K Tan; Mei Huang; Laura Diekman; MD Mayes; John D Reveille; Sandeep K Agarwal
Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.
Arthritis research & therapy 2009;11(5):R147.
2008: Frank Wang; Luis Garza; Soyun Cho; Reza Kafi; Craig Hammerberg; Taihao Quan; Ted Hamilton; MD Mayes; Voravit Ratanatharathorn; John J Voorhees; Gary J Fisher; Sewon Kang
Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.
Archives of dermatology 2008;144(7):851-8.
2008: Arnold E Postlethwaite; Weng Kee Wong; Philip Clements; Soumya Chatterjee; Barri J Fessler; Andrew H Kang; Joseph Korn; MD Mayes; Peter A Merkel; Jerry A Molitor; Larry Moreland; Naomi Rothfield; Robert W Simms; Edwin A Smith; Robert Spiera; Virginia Steen; Kenneth Warrington; Barbara A White; Fredrick M Wigley; Daniel E Furst
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.
Arthritis and rheumatism 2008;58(6):1810-22.
2008: Peter A Merkel; Nancy P Silliman; Christopher P Denton; Daniel E Furst; Dinesh Khanna; Paul Emery; Vivien M Hsu; James B Streisand; Richard P Polisson; Anita Akesson; John Coppock; Frank van den Hoogen; Ariane Herrick; MD Mayes; douglas veale; James R Seibold; Carol M Black; Joseph H Korn
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
Arthritis and rheumatism 2008;59(5):699-705.
2008: Dinesh Khanna; D J Lovell; E Giannini; Philip J Clements; Peter A Merkel; James R Seibold; Marco Matucci-Cerinic; C P Denton; MD Mayes; Virginia D Steen; John Varga; Daniel E Furst
Development of a provisional core set of response measures for clinical trials of systemic sclerosis.
Annals of the rheumatic diseases 2008;67(5):703-9.
2008: pravitt gourh; MD Mayes; Frank C Arnett
CTGF polymorphism associated with systemic sclerosis.
The New England journal of medicine 2008;358(3):308-9; author reply 309.
2008: Charles G Helmick; David T Felson; Reva Lawrence; Sherine Gabriel; Rosemarie Hirsch; C Kent Kwoh; Matthew H Liang; Hilal Maradit Kremers; MD Mayes; Peter A Merkel; Stanley R Pillemer; John D Reveille; John H Stone
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.
Arthritis and rheumatism 2008;58(1):15-25.
2007: Philip J Clements; Michael D Roth; Robert Elashoff; Donald P Tashkin; Jonathan G Goldin; Richard M Silver; Mildred G Sterz; James R Seibold; Dean E Schraufnagel; Robert W Simms; Marcy B Bolster; Robert Wise; Virginia Steen; MD Mayes; Kari Connelly; Mark L Metersky; Daniel E Furst
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
Annals of the rheumatic diseases 2007;66(12):1641-7.
2007: Donald P Tashkin; Robert Elashoff; Philip J Clements; Michael D Roth; Daniel E Furst; Richard M Silver; Jonathan Goldin; Edgar Arriola; Charlton B. Strange; Marcy B Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick M Wigley; Barbara A White; Virginia Steen; Charles Read; MD Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky; Dinesh Khanna; Ning Li; Gang Li
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
American journal of respiratory and critical care medicine 2007;176(10):1026-34.
2007: Dinesh Khanna; Ron Hays; Grace S Park; Yolanda Braun-Moscovici; MD Mayes; Terry A McNearney; Vivien Hsu; Philip J Clements; Daniel E Furst
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument.
Arthritis and rheumatism 2007;57(7):1280-6.
2007: Maria E Suarez-Almazor; Michael A Kallen; Aimee K Roundtree; MD Mayes
Disease and symptom burden in systemic sclerosis: a patient perspective.
The Journal of rheumatology 2007;34(8):1718-26.
2007: Firas Alkassab; pravitt gourh; Filemon K Tan; Terry A McNearney; Michael Fischbach; Chul Ahn; Frank C Arnett; MD Mayes
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis.
Rheumatology (Oxford, England) 2007;46(8):1248-51.
2007: Shervin Assassi; Frank C Arnett; John D Reveille; pravitt gourh; MD Mayes
Clinical, immunologic, and genetic features of familial systemic sclerosis.
Arthritis and rheumatism 2007;56(6):2031-7.
2007: Dinesh Khanna; Xiaohong Yan; Donald P Tashkin; Daniel E Furst; Robert Elashoff; Michael D Roth; Richard M Silver; Charlton B. Strange; Marcy B Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick M Wigley; Barbara A White; Virginia Steen; Charles Read; MD Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky; Philip J Clements
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Arthritis and rheumatism 2007;56(5):1676-84.
2007: Terry A McNearney; John D Reveille; Michael Fischbach; Alan W Friedman; Jeffrey Lisse; Niti Goel; Filemon K Tan; Xiaodong Zhou; Chul Ahn; Carol A Feghali-Bostwick; Marvin Fritzler; Frank C Arnett; MD Mayes
Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors.
Arthritis and rheumatism 2007;57(2):318-26.
2007: Hashim Gazi; Janet E Pope; Philip Clements; Thomas A Medsger; Richard W Martin; Peter A Merkel; Bashar Kahaleh; Frank A Wollheim; Murray Baron; Mary Ellen Csuka; Paul Emery; Jill F Belch; Samina Hayat; Edward V Lally; Joseph H Korn; Laszlo Czirjak; Ariane Herrick; Alexander E Voskuyl; Pius Bruehlmann; Murat Inanc; Daniel E Furst; Carol Black; Michael H Ellman; Larry W Moreland; Naomi F Rothfield; Vivien Hsu; MD Mayes; Kevin M McKown; Thomas Krieg; James R Siebold
Outcome measurements in scleroderma: results from a delphi exercise.
The Journal of rheumatology 2007;34(3):501-9.
2007: MD Mayes; Maria Trojanowska
Genetic factors in systemic sclerosis.
Arthritis research & therapy 2007;9 Suppl 2():S5.
2007: Christopher P Denton; Peter A Merkel; Daniel E Furst; Dinesh Khanna; Paul Emery; Vivien M Hsu; Nancy Silliman; James Streisand; John Powell; Anita Akesson; John Coppock; Frank van den Hoogen; Ariane Herrick; MD Mayes; douglas veale; Joanna Haas; Stephen Ledbetter; Joseph H Korn; Carol M Black; James R Seibold
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192.
Arthritis and rheumatism 2007;56(1):323-33.
2006: pravitt gourh; Filemon K Tan; Shervin Assassi; Chul Ahn; Terry A McNearney; Michael Fischbach; Frank C Arnett; MD Mayes
Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
Arthritis and rheumatism 2006;54(12):3945-53.
2006: Sou-Pan Wu; Lin Leng; Zeny Feng; Nianjun Liu; Hongyu Zhao; Courtney McDonald; Annette Lee; Frank C Arnett; Peter K Gregersen; MD Mayes; Richard Bucala
Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma.
Arthritis and rheumatism 2006;54(11):3661-9.
2006: Dinesh Khanna; Daniel E Furst; Ron Hays; Grace S Park; Weng Kee Wong; James R Seibold; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.
Annals of the rheumatic diseases 2006;65(10):1325-9.
2006: Donald P Tashkin; Robert Elashoff; Philip J Clements; Jonathan Goldin; Michael D Roth; Daniel E Furst; Edgar Arriola; Richard M Silver; Charlton B. Strange; Marcy B Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick M Wigley; Barbara A White; Virginia Steen; Charles Read; MD Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky
Cyclophosphamide versus placebo in scleroderma lung disease.
The New England journal of medicine 2006;354(25):2655-66.
2006: Humphrey Gardner; Jeffrey R Shearstone; Raj Bandaru; Thomas Crowell; Matthew Lynes; Maria Trojanowska; Jaspreet Pannu; Edwin A Smith; Stefania Jablonska; Maria Blaszczyk; Filemon K Tan; MD Mayes
Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts.
Arthritis and rheumatism 2006;54(6):1961-73.
2006: Filemon K Tan; X Zhou; MD Mayes; pravitt gourh; X Guo; C Marcum; L Jin; Frank C Arnett
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.
Rheumatology (Oxford, England) 2006;45(6):694-702.
2005: Linda M Griffith; Steven Z Pavletic; Alan Tyndall; Christopher N Bredeson; James D Bowen; Richard W Childs; Alois Gratwohl; Jacob M van Laar; MD Mayes; Roland Martin; Peter A McSweeney; Paolo A Muraro; Harry Openshaw; Riccardo Saccardi; Brenda M Sandmaier; Stephen J Forman; Richard A Nash
Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(11):862-70.
2005: MD Mayes
Race, scleroderma, and survival: why is there a difference?
The Journal of rheumatology 2005;32(10):1873-4.
2005: Shervin Assassi; MD Mayes; Terry A McNearney; Michael Fischbach; John D Reveille; Frank C Arnett; Filemon K Tan
Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis.
The American journal of medicine 2005;118(8):907-11.
2005: Soumya Chatterjee; George W Dombi; Richard K Severson; MD Mayes
Risk of malignancy in scleroderma: a population-based cohort study.
Arthritis and rheumatism 2005;52(8):2415-24.
2005: Fredrick M Wigley; João A C Lima; MD Mayes; David McLain; J Lincoln Chapin; Clive Ward-Able
The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
Arthritis and rheumatism 2005;52(7):2125-32.
2005: Dinesh Khanna; Daniel E Furst; Philip J Clements; Grace S Park; Ron Hays; Jeonglim Yoon; Joseph H Korn; Peter A Merkel; Naomi F Rothfield; Fredrick M Wigley; Larry W Moreland; Richard M Silver; Virginia Steen; Michael Weisman; MD Mayes; David H Collier; Thomas A Medsger; James R Seibold
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
The Journal of rheumatology 2005;32(5):832-40.
2005: Philip B Furspan; S Chatterjee; MD Mayes; Robert R Freedman
Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon.
Rheumatology (Oxford, England) 2005;44(4):488-94.
2005: Filemon K Tan; Bernard August Hildebrand; Malisa S Lester; David N Stivers; Stanley Pounds; Xiaodong Zhou; Debra D Wallis; Dianna M Milewicz; John D Reveille; MD Mayes; Li Jin; Frank C Arnett
Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease.
Arthritis and rheumatism 2005;52(3):865-76.
2005: Dinesh Khanna; Philip J Clements; Daniel E Furst; Yun Chon; Robert Elashoff; Michael D Roth; Mildred G Sterz; Joannie Chung; John D FitzGerald; James R Seibold; John Varga; Arthur Theodore; Fredrick M Wigley; Richard M Silver; Virginia Steen; MD Mayes; M Kari Connolly; Barri J Fessler; Naomi F Rothfield; Kamal Mubarak; Jerry Molitor; Donald P Tashkin
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Arthritis and rheumatism 2005;52(2):592-600.
2004: Joseph H Korn; MD Mayes; marco matucci cerinic; Maurizio Rainisio; J Pope; E Hachulla; E Rich; P Carpentier; J Molitor; James R Seibold; V Hsu; L Guillevin; S Chatterjee; H H Peter; J Coppock; Ariane Herrick; Peter A Merkel; Robert W Simms; Christopher P Denton; Daniel E Furst; N Nguyen; M Gaitonde; Carol Black
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
Arthritis and rheumatism 2004;50(12):3985-93.
2004: ola khorshid; Chitra Hosing; Samer Bibawi; Naoto Ueno; John D Reveille; MD Mayes; Richard E Champlin
Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus.
The Journal of rheumatology 2004;31(12):2513-6.
2004: S Chatterjee; M E Mark; Paul H Wooley; W Dwayne Lawrence; MD Mayes
Increased dermal elastic fibers in the tight skin mouse.
Clinical and experimental rheumatology 2004;22(5):617-20.
2004: Philip J Clements; James R Seibold; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael D Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Weng Kee Wong
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
Seminars in arthritis and rheumatism 2004;33(4):249-63.
2004: MD Mayes; Daniel O'Donnell; Naomi F Rothfield; Mary Ellen Csuka
Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
Arthritis and rheumatism 2004;50(2):553-7.
2003: MD Mayes; James V Lacey; Jennifer L Beebe; Brenda W Gillespie; Brenda Cooper; Timothy J Laing; David Schottenfeld
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.
Arthritis and rheumatism 2003;48(8):2246-55.
2003: MD Mayes
Scleroderma epidemiology.
Rheumatic diseases clinics of North America 2003;29(2):239-54.
2003: MD Mayes
Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
Arthritis and rheumatism 2003;48(5):1190-9.
2003: David H Garabrant; James V Lacey; Timothy J Laing; Brenda W Gillespie; MD Mayes; Brenda C Cooper; David Schottenfeld
Scleroderma and solvent exposure among women.
American journal of epidemiology 2003;157(6):493-500.
2003: V D Steen; MD Mayes; Peter A Merkel
Assessment of kidney involvement.
Clinical and experimental rheumatology 2003;21(3 Suppl 29):S29-31.
2002: Paul J DeMarco; Michael H Weisman; James R Seibold; Daniel E Furst; Weng Kee Wong; Eric L Hurwitz; MD Mayes; Barbara A White; Fredrick M Wigley; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
Arthritis and rheumatism 2002;46(11):2983-9.
2002: Peter A Merkel; Karen Herlyn; Richard W Martin; Jennifer J Anderson; MD Mayes; Patrice Bell; Joseph H Korn; Robert W Simms; Mary Ellen Csuka; Thomas A Medsger; Naomi F Rothfield; Michael H Ellman; David H Collier; Arthur Weinstein; Daniel E Furst; Sergio A Jiménez; Barbara A White; James R Seibold; Fredrick M Wigley
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Arthritis and rheumatism 2002;46(9):2410-20.
2002: Barbara J Doss; Faisal Qureshi; MD Mayes; Suzanne M Jacques
Vascular and connective tissue histopathologic alterations of the female lower genital tract in scleroderma.
The Journal of rheumatology 2002;29(7):1384-7.
2002: Reda E Girgis; Manish K Gugnani; Judith Abrams; MD Mayes
Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease.
American journal of respiratory and critical care medicine 2002;165(12):1587-91.
2001: Philip B Furspan; MD Mayes; Robert R Freedman
Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenon.
The Journal of rheumatology 2001;28(10):2263-8.
2001: Timothy J Laing; David Schottenfeld; James V Lacey; Brenda W Gillespie; David H Garabrant; Brenda C Cooper; Steven G Heeringa; KH Alcser; MD Mayes
Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devices.
American journal of epidemiology 2001;154(7):610-7.
2001: Daniel E Furst; Philip J Clements; W K Wong; MD Mayes; Fredrick M Wigley; Barbara A White; Michael Weisman; W Barr; Larry Moreland; R Martin; Thomas A Medsger; Virginia Steen; D Collier; A Weinstein; Edward Lally; J Varga; Steven R Weiner; B Andrews; Micha Abeles; J B Peter; James R Seibold
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
Rheumatology (Oxford, England) 2001;40(6):615-22.
2001: Frank C Arnett; M Cho; S Chatterjee; M B Aguilar; John D Reveille; MD Mayes
Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts.
Arthritis and rheumatism 2001;44(6):1359-62.
2001: Philip J Clements; Weng Kee Wong; Eric L Hurwitz; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; James R Seibold
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
Arthritis and rheumatism 2001;44(3):653-61.
2001: Robert R Freedman; Reda E Girgis; MD Mayes
Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
The Journal of rheumatology 2001;28(1):119-21.
2000: MD Mayes
The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis.
Current rheumatology reports 2000;2(6):512-6.
2000: Philip J Clements; Eric L Hurwitz; Weng Kee Wong; James R Seibold; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Daniel E Furst
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
Arthritis and rheumatism 2000;43(11):2445-54.
2000: James R Seibold; Joseph H Korn; Robert W Simms; Philip J Clements; Larry W Moreland; MD Mayes; Daniel E Furst; Naomi F Rothfield; Virginia Steen; Michael Weisman; D Collier; Fredrick M Wigley; Peter A Merkel; Mary Ellen Csuka; V Hsu; S Rocco; ME Erikson; JF Hannigan; W S Harkonen; M E Sanders
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.
Annals of internal medicine 2000;132(11):871-9.
2000: Frederick W Miller; E V Hess; Daniel J Clauw; P A Hertzman; T Pincus; Richard M Silver; MD Mayes; J Varga; Thomas A Medsger; Lori A Love
Approaches for identifying and defining environmentally associated rheumatic disorders.
Arthritis and rheumatism 2000;43(2):243-9.
2000: MD Mayes
Photopheresis and autoimmune diseases.
Rheumatic diseases clinics of North America 2000;26(1):75-81, viii-ix.
1999: Robert R Freedman; Reda E Girgis; MD Mayes
Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
The Journal of rheumatology 1999;26(11):2386-8.
1999: Philip J Clements; Weng Kee Wong; Eric L Hurwitz; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; R Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; S Weiner; Brian Andrews; Micha Abeles; James R Seibold
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
Arthritis and rheumatism 1999;42(11):2372-80.
1999: MD Mayes
Epidemiologic studies of environmental agents and systemic autoimmune diseases.
Environmental health perspectives 1999;107 Suppl 5():743-8.
1999: Robert R Freedman; Reda E Girgis; MD Mayes
Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma.
Lancet 1999;354(9180):739.
1999: Philip J Clements; Daniel E Furst; Weng Kee Wong; MD Mayes; Barbara A White; Fredrick M Wigley; Michael H Weisman; Water Barr; L W Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; S Weiner; Brian Andrews; Micha Abeles; James R Seibold
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Arthritis and rheumatism 1999;42(6):1194-203.
1999: James V Lacey; David H Garabrant; Timothy J Laing; Brenda W Gillespie; MD Mayes; Brenda C Cooper; David Schottenfeld
Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD).
American journal of epidemiology 1999;149(8):761-70.
1999: T Z Kirk; MD Mayes
IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death.
Biochemical and biophysical research communications 1999;255(1):129-32.
1998: Barbara J Doss; Suzanne M Jacques; MD Mayes; Faisal Qureshi
Maternal scleroderma: placental findings and perinatal outcome.
Human pathology 1998;29(12):1524-30.
1998: Fredrick M Wigley; Joseph H Korn; Mary Ellen Csuka; Thomas A Medsger; Naomi F Rothfield; Michael H Ellman; R Martin; David H Collier; Arthur Weinstein; Daniel E Furst; Sergio A Jimenez; MD Mayes; Peter A Merkel; B Gruber; L Kaufman; John Varga; P Bell; J Kern; P Marrott; Barbara A White; Robert W Simms; A C Phillips; James R Seibold
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
Arthritis and rheumatism 1998;41(4):670-7.
1998: MD Mayes
Classification and epidemiology of scleroderma.
Seminars in cutaneous medicine and surgery 1998;17(1):22-6.
1998: James R Seibold; Philip J Clements; Daniel E Furst; MD Mayes; Deborah A McCloskey; Larry W Moreland; Barbara A White; Fredrick M Wigley; S Rocco; ME Erikson; JF Hannigan; M E Sanders; E P Amento
Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis.
The Journal of rheumatology 1998;25(2):302-7.
1997: MD Mayes
Epidemiology of systemic sclerosis and related diseases.
Current opinion in rheumatology 1997;9(6):557-61.
1997: MD Mayes; Edward H Giannini; Lauren M Pachman; J P Buyon; P Fleckman
Connective tissue disease registries.
Arthritis and rheumatism 1997;40(9):1556-9.
1997: Timothy J Laing; Brenda W Gillespie; M B Toth; MD Mayes; R H Gallavan; C J Burns; JR Johanns; Brenda C Cooper; B J Keroack; M C Wasko; James V Lacey; David Schottenfeld
Racial differences in scleroderma among women in Michigan.
Arthritis and rheumatism 1997;40(4):734-42.
1996: Pamela Keenan; M W Jacobson; R M Soleymani; MD Mayes; M E Stress; D T Yaldoo
The effect on memory of chronic prednisone treatment in patients with systemic disease.
Neurology 1996;47(6):1396-402.
1996: MD Mayes
Scleroderma epidemiology.
Rheumatic diseases clinics of North America 1996;22(4):751-64.
1996: C J Burns; Timothy J Laing; Brenda W Gillespie; Steven G Heeringa; KH Alcser; MD Mayes; M C Wasko; Brenda C Cooper; David H Garabrant; David Schottenfeld
The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica.
The Journal of rheumatology 1996;23(11):1904-11.
1996: Robert R Freedman; MD Mayes
Familial aggregation of primary Raynaud's disease.
Arthritis and rheumatism 1996;39(7):1189-91.
1995: Larry W Moreland; P W Pratt; MD Mayes; A Postlethwaite; M H Weisman; T Schnitzer; R Lightfoot; L Calabrese; D J Zelinger; J N Woody
Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.
Arthritis and rheumatism 1995;38(11):1581-8.
1995: Robert R Freedman; R P Baer; MD Mayes
Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease.
Circulation 1995;92(6):1448-51.
1995: P Clements; P Lachenbruch; J Siebold; Barbara A White; S Weiner; R Martin; A Weinstein; M Weisman; MD Mayes; David Collier
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
The Journal of rheumatology 1995;22(7):1281-5.
1995: David Schottenfeld; C J Burns; B W Gillespie; Timothy J Laing; MD Mayes; Steven G Heeringa; KH Alcser
The design of a population-based case-control study of systemic sclerosis (scleroderma): commentary on the University of Michigan study.
Journal of clinical epidemiology 1995;48(4):583-6.
1995: T Z Kirk; M E Mark; Chu Chang Chua; Balvin H L Chua; MD Mayes
Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1.
The Journal of biological chemistry 1995;270(7):3423-8.
1994: Fredrick M Wigley; Robert Wise; James R Seibold; D A McCloskey; G Kujala; Thomas A Medsger; Virginia D Steen; John Varga; S Jimenez; MD Mayes; P J Clements; S R Weiner; J Porter; M Ellman; C Wise; L D Kaufman; J Williams; W Dole
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.
Annals of internal medicine 1994;120(3):199-206.
1994: Daniel O Clegg; James C Reading; MD Mayes; James R Seibold; C Harris; Fredrick M Wigley; J R Ward; E J Pisko; M H Weisman; P Lee
Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.
The Journal of rheumatology 1994;21(1):105-10.
1993: Robert R Freedman; M Moten; P Migály; MD Mayes
Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease.
Arthritis and rheumatism 1993;36(5):685-90.
1991: Robert R Freedman; D Keegan; P Migály; matthew galloway; MD Mayes
Plasma catecholamines during behavioral treatments for Raynaud's disease.
Psychosomatic medicine 1991;53(4):433-9.
1990: Robert L Karvonen; W G Negendank; S M Fraser; MD Mayes; T An; Felix R Fernandez-Madrid
Articular cartilage defects of the knee: correlation between magnetic resonance imaging and gross pathology.
Annals of the rheumatic diseases 1990;49(9):672-5.
1989: Robert R Freedman; MD Mayes; S C Sabharwal
Digital nerve blockade in Raynaud's disease.
Circulation 1989;80(6):1923-4.
1989: Robert R Freedman; MD Mayes; S C Sabharwal
Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenon.
Circulation 1989;80(4):859-62.
1989: E R Walker; R G Frederickson; MD Mayes
The mineralization of elastic fibers and alterations of extracellular matrix in pseudoxanthoma elasticum. Ultrastructure, immunocytochemistry, and X-ray analysis.
Archives of dermatology 1989;125(1):70-6.
1989: Robert R Freedman; S C Sabharal; N Desai; P Wenig; MD Mayes
Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease.
Arthritis and rheumatism 1989;32(1):61-5.
1988: Robert R Freedman; M Morris; D A Norton; D Masselink; S C Sabharwal; MD Mayes
Physiological mechanism of digital vasoconstriction training.
Biofeedback and self-regulation 1988;13(4):299-305.
1988: Robert R Freedman; S C Sabharwal; P Ianni; N Desai; P Wenig; MD Mayes
Nonneural beta-adrenergic vasodilating mechanism in temperature biofeedback.
Psychosomatic medicine 1988;50(4):394-401.
1988: MD Mayes; E R Walker; R G Frederickson; R K Prince; A G DiBartolomeo
The characterization of normal and scleroderma skin fibroblasts cultured in a collagen gel matrix.
The Journal of rheumatology 1988;15(2):268-75.